Trial Profile
Early phase II clinical study with AT-877ER in patients with pulmonary arterial hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 May 2016
Price :
$35
*
At a glance
- Drugs Fasudil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- Sponsors Asahi Kasei Pharma Corp
- 26 May 2016 New trial record